CN103627756A - Method for enzymatic synthesis of isoquercitrin by using continuous-flow tubular microreactor - Google Patents
Method for enzymatic synthesis of isoquercitrin by using continuous-flow tubular microreactor Download PDFInfo
- Publication number
- CN103627756A CN103627756A CN201310611377.6A CN201310611377A CN103627756A CN 103627756 A CN103627756 A CN 103627756A CN 201310611377 A CN201310611377 A CN 201310611377A CN 103627756 A CN103627756 A CN 103627756A
- Authority
- CN
- China
- Prior art keywords
- isoquercitrin
- continuous
- microreactor
- concentration
- flow tubular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 title claims abstract description 39
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 title claims abstract description 38
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 title claims abstract description 38
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title claims abstract description 20
- 230000015572 biosynthetic process Effects 0.000 title description 8
- 230000002255 enzymatic effect Effects 0.000 title description 8
- 238000003786 synthesis reaction Methods 0.000 title description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims abstract description 27
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims abstract description 27
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims abstract description 27
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims abstract description 27
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims abstract description 27
- 235000005493 rutin Nutrition 0.000 claims abstract description 27
- 229960004555 rutoside Drugs 0.000 claims abstract description 27
- 108090000790 Enzymes Proteins 0.000 claims abstract description 22
- 102000004190 Enzymes Human genes 0.000 claims abstract description 22
- 239000002608 ionic liquid Substances 0.000 claims abstract description 14
- 239000012153 distilled water Substances 0.000 claims abstract description 10
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 9
- 108010030923 hesperidinase Proteins 0.000 claims abstract description 5
- 239000012452 mother liquor Substances 0.000 claims abstract description 5
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 4
- IQQRAVYLUAZUGX-UHFFFAOYSA-N 1-butyl-3-methylimidazolium Chemical compound CCCCN1C=C[N+](C)=C1 IQQRAVYLUAZUGX-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000003054 catalyst Substances 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims abstract 3
- 239000000243 solution Substances 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 15
- 239000007853 buffer solution Substances 0.000 claims description 9
- 239000012295 chemical reaction liquid Substances 0.000 claims description 7
- 238000001746 injection moulding Methods 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- 238000005530 etching Methods 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- 238000000520 microinjection Methods 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 5
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 4
- 235000014676 Phragmites communis Nutrition 0.000 claims 1
- 238000011095 buffer preparation Methods 0.000 claims 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 239000000872 buffer Substances 0.000 abstract description 2
- 241001116389 Aloe Species 0.000 abstract 1
- 235000011399 aloe vera Nutrition 0.000 abstract 1
- 230000002210 biocatalytic effect Effects 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 239000010413 mother solution Substances 0.000 description 14
- 230000036983 biotransformation Effects 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 6
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 6
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 6
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 6
- 229940025878 hesperidin Drugs 0.000 description 6
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 6
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 6
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- -1 flavonoid compound Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- BPJXSLLUNRTWHM-UHFFFAOYSA-N n-propyl caffeate Natural products CCCOC(=O)C=CC1=CC=C(O)C(O)=C1 BPJXSLLUNRTWHM-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BPJXSLLUNRTWHM-GQCTYLIASA-N propyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(O)C(O)=C1 BPJXSLLUNRTWHM-GQCTYLIASA-N 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
利用连续流动的管式微反应器酶促合成异槲皮苷的方法,采用微米级别内径的连续流动的管式微反应器,以pH9的甘氨酸-NaOH为缓冲液配制浓度为0.01~5g/L的芦丁母液,以橙皮苷酶为催化剂,酶用蒸馏水按浓度0.001g/mL~0.1g/mL配比,在反应体系中加入离子液体[Bmim][BF4],芦丁母液、酶液和离子液体分别按体积比72:18:10配比,用微量注射泵以0.1~100μL/min的流速,将反应液泵入微反应器中进行酶促反应,温度控制在20-60℃。该方法是一种省时高效的生物催化(转化)方法,有利于大规模制备异槲皮苷。
A method for enzymatically synthesizing isoquercitrin using a continuous-flow tubular microreactor, adopting a continuous-flow tubular microreactor with a micron-level inner diameter, using glycine-NaOH at pH 9 as a buffer to prepare aloe with a concentration of 0.01 to 5 g/L Ding mother liquor, with hesperidinase as a catalyst, distilled water for enzyme proportioning at a concentration of 0.001g/mL~0.1g/mL, adding ionic liquid [Bmim][BF 4 ], rutin mother liquor, enzyme liquid and The ionic liquids were prepared in a volume ratio of 72:18:10, and the reaction solution was pumped into the microreactor at a flow rate of 0.1-100 μL/min by a micro-syringe pump to carry out the enzymatic reaction, and the temperature was controlled at 20-60 °C. This method is a time-saving and efficient biocatalytic (transformation) method, which is beneficial to the large-scale preparation of isoquercitrin.
Description
技术领域technical field
本发明涉及生化制药领域,具体涉及一种利用连续流微反应器酶促合成异槲皮苷的方法。The invention relates to the field of biochemical pharmacy, in particular to a method for enzymatically synthesizing isoquercitrin by using a continuous flow microreactor.
背景技术Background technique
异槲皮苷是一种具有抗肿瘤、抗氧化和降血糖等生物活性的天然黄酮类化合物,是是食品着色剂(Enzymatically modified isoquercitrin)EMIQ的合成中间体(Food Chem.,2009,116(1):214-219)。异槲皮苷可以从桑叶、田基黄等植物中提取,如CN102827220A公开了从荷叶中用柱层析法来分离得到异槲皮苷,但是天然产物中异槲皮苷含量极低,远远无法满足市场需求。此外,异槲皮苷可通过化学法制备,如CN1817876A公开了一种在高压反应釜里加热水解芦丁制备异槲皮苷,但是产物中异槲皮苷和槲皮素共存,其中异槲皮苷最高得率只有13%,大部分是槲皮素。因此,考虑到提取法和化学法成本过高,近年来酶促选择性水解芦丁制备异槲皮苷是公认的有效途径。Isoquercitrin is a natural flavonoid compound with biological activities such as anti-tumor, anti-oxidation and hypoglycemia, and is a synthetic intermediate of food colorant (Enzymatically modified isoquercitrin) EMIQ (Food Chem. ):214-219). Isoquercitrin can be extracted from plants such as mulberry leaves and Tianjihuang. For example, CN102827220A discloses that isoquercitrin is separated from lotus leaves by column chromatography, but the content of isoquercitrin in natural products is extremely low. far from meeting market demand. In addition, isoquercitrin can be prepared by chemical methods. For example, CN1817876A discloses a method of heating and hydrolyzing rutin in a high-pressure reactor to prepare isoquercitrin. However, isoquercitrin and quercetin coexist in the product, and isoquercitrin The highest yield of glycosides is only 13%, most of which are quercetin. Therefore, considering the high cost of extraction and chemical methods, enzymatic selective hydrolysis of rutin to prepare isoquercitrin has been recognized as an effective way in recent years.
以价格低廉的芦丁为底物,对其鼠李糖苷键进行酶法选择性水解获得异槲皮苷,为异槲皮苷的生产提供了新的思路。如Petr等用鼠李糖苷酶催化芦丁水解产异槲皮苷,反应25h转化率可达93%(Bioresour.Technol.,2011,115(0):222-227)。但是,该水解过程酶切效率较低,反应时间长,酶的价格昂贵且重复利用度低,这都限制了异槲皮苷的生产效率。Wang等在新型的离子液体共溶剂反应体系中,用橙皮苷酶水解芦丁产异槲皮苷,反应10h转化率就可达93.4%(Bioresour.Technol.,2013,128,156-163),该方法相对于传统方法在反应时间上大为缩短,但仍有待进一步完善。因此,急需在此催化新体系基础上寻找一种制备异槲皮苷更加高效的新技术。Isoquercitrin was obtained by selective enzymatic hydrolysis of rhamnoside bond with cheap rutin as substrate, which provided a new idea for the production of isoquercitrin. For example, Petr et al. used rhamnosidase to catalyze the hydrolysis of rutin to produce isoquercitrin, and the conversion rate could reach 93% after 25 hours of reaction (Bioresour.Technol., 2011, 115(0):222-227). However, the enzymatic cleavage efficiency of this hydrolysis process is low, the reaction time is long, the enzyme is expensive and the reusability is low, which all limit the production efficiency of isoquercitrin. In a novel ionic liquid co-solvent reaction system, Wang et al. used hesperidinase to hydrolyze rutin to produce isoquercitrin, and the conversion rate could reach 93.4% after 10 hours of reaction (Bioresour.Technol., 2013, 128, 156-163). Compared with the traditional method, the method greatly shortens the reaction time, but it still needs to be further improved. Therefore, it is urgent to find a more efficient new technology for preparing isoquercitrin based on this new catalytic system.
自20世纪90年代中期微反应器技术兴起以来,由于其独特的特色和优势迅速成为研究热点,在生物催化领域中得到了越来越多的应用。连续流管式微反应器(Continuous-flowmicroreactor)是一种连续流动的管道式反应器,其反应空间的尺寸数量级一般为微米甚至纳米。与常规反应器相比,连续流管式微反应器具有表面积大,传质、传热效率高、便于放大等优点(Lab Chip.,2012,12,4080-4084)。Du等研究了在微反应器中用脂肪酶TLIM催化糖酯的合成,其将脂肪酶固定在2mm内的管道中。与传统的反应器比较,其反应30min就可以达到90%左右的得率,同时副产物更少了(RSC Adv.,2012,2,2663-2665)。然而,尚未见用连续流管式微反应器酶促水解芦丁合成异槲皮苷的方法。Since the rise of microreactor technology in the mid-1990s, it has rapidly become a research hotspot due to its unique features and advantages, and has been used more and more in the field of biocatalysis. Continuous-flow microreactor (Continuous-flow microreactor) is a continuous-flow tubular reactor, and the size of its reaction space is generally on the order of microns or even nanometers. Compared with conventional reactors, continuous flow tubular microreactors have the advantages of large surface area, high mass transfer and heat transfer efficiency, and easy scale-up (Lab Chip., 2012, 12, 4080-4084). Du et al studied the synthesis of sugar esters catalyzed by lipase TLIM in a microreactor, which immobilized the lipase in the pipe within 2 mm. Compared with traditional reactors, the yield of about 90% can be achieved within 30 minutes, and the by-products are less (RSC Adv., 2012, 2, 2663-2665). However, there is no method for enzymatically hydrolyzing rutin to synthesize isoquercitrin with a continuous flow tube microreactor.
因此,本发明首次利用连续流管式微反应器来酶促水解芦丁合成异槲皮苷,有利于提高酶促反应效率,缩短反应时间,减少耗能,且操作简单,易于工业化生产高纯度的异槲皮苷,为推动其在化妆品、药品、食品等工业中具有十分重要的意义。Therefore, for the first time, the present invention uses a continuous flow tube microreactor to enzymatically hydrolyze rutin to synthesize isoquercitrin, which is beneficial to improve the efficiency of the enzymatic reaction, shorten the reaction time, reduce energy consumption, and is simple to operate and easy to industrialize the production of high-purity Isoquercitrin is of great significance to promote its use in cosmetics, pharmaceuticals, food and other industries.
发明内容Contents of the invention
解决的技术问题:本发明提供了一种利用连续流管式微反应器酶促合成咖啡酸丙酯的方法,以解决现有技术中存在的合成异槲皮苷的反应速率低、耗时长及难以连续化生产等问题。Technical problem to be solved: The present invention provides a method for enzymatically synthesizing propyl caffeate using a continuous flow tube microreactor to solve the problems of low reaction rate, long time-consuming and difficult synthesis of isoquercitrin in the prior art. issues of continuous production.
技术方案:利用连续流动的管式微反应器酶促合成异槲皮苷的方法,采用微米级别内径的连续流动的管式微反应器,以pH9的甘氨酸-NaOH为缓冲液配制浓度为0.01~5g/L的芦丁母液,以橙皮苷酶为催化剂,酶用蒸馏水按浓度0.001g/mL~0.1g/mL配比,在反应体系中加入离子液体[Bmim][BF4],芦丁母液、酶液和离子液体分别按体积比72:18:10配比,用微量注射泵以0.1~100μL/min的流速,将反应液泵入微反应器中进行酶促反应,温度控制在20-60℃。Technical solution: The method of enzymatically synthesizing isoquercitrin by using a continuous-flow tubular microreactor, using a continuous-flow tubular microreactor with a micron-level inner diameter, and using glycine-NaOH with pH 9 as a buffer to prepare a concentration of 0.01-5g/ L of rutin mother liquor, using hesperidinase as a catalyst, and distilled water for the enzyme in a ratio of 0.001g/mL to 0.1g/mL, adding ionic liquid [Bmim][BF 4 ], rutin mother liquor, Enzyme solution and ionic liquid are mixed according to the volume ratio of 72:18:10, and the reaction solution is pumped into the microreactor with a flow rate of 0.1-100μL/min by a micro-syringe pump to carry out the enzymatic reaction, and the temperature is controlled at 20-60℃ .
所述管式微反应器设有依次连接的进样口、微管道和出样口,反应器的进样口端与微量注射泵连接,反应器的出样口端与收集器连接,微管道为蛇形通道,通过热注塑法或是蚀刻法刻出,通道的尺寸内径为长0.25m-2m,宽100-500μm,深50μm,微反应器材质为玻璃、PDMS(polydimethylsiloxane)或PMMA(Poly(methyl methacrylate))。The tubular microreactor is provided with a sample inlet, a micropipe and a sample outlet connected in sequence, the sample inlet end of the reactor is connected with a micro-injection pump, the sample outlet end of the reactor is connected with a collector, and the micropipe is The serpentine channel is carved by thermal injection molding or etching. The inner diameter of the channel is 0.25m-2m long, 100-500μm wide, and 50μm deep. The microreactor is made of glass, PDMS (polydimethylsiloxane) or PMMA (Poly( methyl methacrylate)).
所述的缓冲液中芦丁的浓度优选为0.1g/L。The concentration of rutin in the buffer solution is preferably 0.1 g/L.
所述的酶液浓度优选为为0.1g/mL。The concentration of the enzyme solution is preferably 0.1 g/mL.
所述的用微量注射泵控制的流速优选为2μL/min。The flow rate controlled by the micro-syringe pump is preferably 2 μL/min.
有益效果:Beneficial effect:
本发明选择利用连续流管式微反应器酶促合成异槲皮苷,将传统反应时间由10h缩减为30min,得率即可达到100%,大大减少了耗能,反应效率大大提高;生产过程由间隙式操作变为连续操作,可以持续生产。此外,本发明采用的装置结构简单,只需简单的将数目放大即可等比例的扩大生产能力,具有良好的工业化应用前景,可以满足迅速发展的医药工业需要。The present invention chooses to utilize the continuous flow tube type microreactor to enzymatically synthesize isoquercitrin, the traditional reaction time is reduced from 10h to 30min, the yield can reach 100%, the energy consumption is greatly reduced, and the reaction efficiency is greatly improved; the production process consists of Intermittent operation becomes continuous operation and continuous production is possible. In addition, the device adopted in the present invention has a simple structure, and the production capacity can be expanded in equal proportion by simply increasing the number, has good industrial application prospects, and can meet the needs of the rapidly developing pharmaceutical industry.
附图说明Description of drawings
图1为本发明的酶促合成异槲皮苷反应式及连续流动的管式微反应器装置图,图中1微量注射泵、2微管道、3收集器;Fig. 1 is the tubular microreactor device figure of enzymatic synthesis isoquercitrin reaction formula and continuous flow of the present invention, among the figure 1 micro injection pump, 2 micropipes, 3 collectors;
图2为连续流动的管式微反应器装置管道放大示意图,图中4进样口、2微管道、5出样口。Figure 2 is an enlarged schematic diagram of the continuous flow tubular microreactor device pipeline, in which there are 4 sample inlets, 2 micropipes, and 5 sample outlets.
具体实施方式Detailed ways
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。Below in conjunction with specific embodiment, further illustrate the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.
实施例1Example 1
以甘氨酸-氢氧化钠缓冲液配制pH为9的5g/L的芦丁母液,以蒸馏水配制浓度为0.001g/mL的橙皮苷酶溶液,芦丁母液、酶溶液和离子液体[Bmin][BF4]分别按体积比为72:18:10配制成生物转化反应体系。将配制好的反应体系通过微量注射泵,以100μL/min的流速泵入到连续流反应器中进行反应。管式微反应器设有依次连接的进样口4、微管道2和出样口5,反应器的进样口端与微量注射泵1连接,反应器的出样口端与收集器3连接,该反应器由PDMS-玻璃材质通过热注塑法制出一条长为0.25m、宽500μm、深50μm的蛇形管道。温度控制在60℃,反应液在反应器中停留36s。收集出口物料,用HPLC检测酶促合成异槲皮苷的得率为2.3%。Prepare 5 g/L rutin mother solution with pH of 9 with glycine-sodium hydroxide buffer solution, prepare hesperidin enzyme solution with concentration of 0.001 g/mL with distilled water, rutin mother solution, enzyme solution and ionic liquid [Bmin][ BF 4 ] were prepared into a biotransformation reaction system at a volume ratio of 72:18:10. The prepared reaction system was pumped into a continuous flow reactor at a flow rate of 100 μL/min through a microsyringe pump for reaction. The tubular microreactor is provided with a
实施例2Example 2
以甘氨酸-氢氧化钠缓冲液配制pH为9的0.01g/L的芦丁母液,以蒸馏水配制浓度为0.1g/mL的橙皮苷酶溶液,芦丁母液、酶溶液和离子液体[Bmin][BF4]分别按体积比为72:18:10配制成生物转化反应体系。将配制好的反应体系通过微量注射泵,以2μL/min的流速泵入到连续流反应器中进行反应。装置结构与实施例1相同,该反应器由PMMA材质通过蚀刻法刻制出一条长为2m、宽100μm、深50μm的蛇形管道。温度控制在20℃,反应液在反应器中停留30min。收集出口物料,用HPLC检测酶促合成异槲皮苷的得率为5.7%。Prepare 0.01g/L rutin mother solution with pH of 9 with glycine-sodium hydroxide buffer solution, prepare hesperidin enzyme solution with concentration of 0.1g/mL with distilled water, rutin mother solution, enzyme solution and ionic liquid [Bmin] [BF 4 ] was prepared into a biotransformation reaction system at a volume ratio of 72:18:10. The prepared reaction system was pumped into a continuous flow reactor at a flow rate of 2 μL/min through a microsyringe pump for reaction. The structure of the device is the same as that of Example 1. The reactor is made of PMMA material by etching to carve a serpentine pipe with a length of 2 m, a width of 100 μm, and a depth of 50 μm. The temperature was controlled at 20°C, and the reaction solution stayed in the reactor for 30 minutes. The export material was collected, and the yield of enzymatic synthesis of isoquercitrin was detected by HPLC to be 5.7%.
实施例3Example 3
以甘氨酸-氢氧化钠缓冲液配制pH为9的0.1g/L的芦丁母液,以蒸馏水配制浓度为0.01g/mL的橙皮苷酶溶液,芦丁母液、酶溶液和离子液体[Bmin][BF4]分别按体积比为72:18:10配制成生物转化反应体系。将配制好的反应体系通过微量注射泵,以20μL/min的流速泵入到连续流反应器中进行反应。装置结构与实施例1相同,该反应器由PDMS材质通过热注塑法制出一条长为1m、宽100μm、深50μm的蛇形管道。温度控制在40℃,反应液在反应器中停留15min。收集出口物料,用HPLC检测酶促合成异槲皮苷的得率为58.6%。Prepare 0.1g/L rutin mother solution with pH of 9 with glycine-sodium hydroxide buffer solution, prepare hesperidin enzyme solution with concentration of 0.01g/mL with distilled water, rutin mother solution, enzyme solution and ionic liquid [Bmin] [BF 4 ] was prepared into a biotransformation reaction system at a volume ratio of 72:18:10. The prepared reaction system was pumped into a continuous flow reactor at a flow rate of 20 μL/min through a micro-syringe pump for reaction. The structure of the device is the same as that of Example 1. The reactor is made of PDMS material and a serpentine pipe with a length of 1 m, a width of 100 μm and a depth of 50 μm is made by thermal injection molding. The temperature was controlled at 40°C, and the reaction liquid stayed in the reactor for 15 minutes. The export material was collected, and the yield of enzymatic synthesis of isoquercitrin detected by HPLC was 58.6%.
实施例4Example 4
以甘氨酸-氢氧化钠缓冲液配制pH为9的0.1g/L的芦丁母液,以蒸馏水配制浓度为0.05g/mL的橙皮苷酶溶液,芦丁母液、酶溶液和离子液体[Bmin][BF4]分别按体积比为72:18:10配制成生物转化反应体系。将配制好的反应体系通过微量注射泵,以10μL/min的流速泵入到连续流反应器中进行反应。装置结构与实施例1相同,该反应器由PMMA材质通过蚀刻法刻制出一条长为2m、宽200μm、深50μm的蛇形管道。温度控制在40℃,反应液在反应器中停留30min。收集出口物料,用HPLC检测酶促合成异槲皮苷的得率为72.1%。Prepare 0.1g/L rutin mother solution with pH of 9 with glycine-sodium hydroxide buffer solution, prepare hesperidin enzyme solution with concentration of 0.05g/mL with distilled water, rutin mother solution, enzyme solution and ionic liquid [Bmin] [BF 4 ] was prepared into a biotransformation reaction system at a volume ratio of 72:18:10. The prepared reaction system was pumped into a continuous flow reactor at a flow rate of 10 μL/min through a microsyringe pump for reaction. The structure of the device is the same as that of Example 1. The reactor is made of PMMA material by etching to carve a serpentine pipe with a length of 2 m, a width of 200 μm, and a depth of 50 μm. The temperature was controlled at 40°C, and the reaction liquid stayed in the reactor for 30 minutes. The export material was collected, and the yield of enzymatic synthesis of isoquercitrin detected by HPLC was 72.1%.
实施例5Example 5
以甘氨酸-氢氧化钠缓冲液配制pH为9的1g/L的芦丁母液,以蒸馏水配制浓度为0.1g/mL的橙皮苷酶溶液,芦丁母液、酶溶液和离子液体[Bmin][BF4]分别按体积比为72:18:10配制成生物转化反应体系。将配制好的反应体系通过微量注射泵,以4μL/min的流速泵入到连续流反应器中进行反应。装置结构与实施例1相同,该反应器由玻璃材质通过蚀刻法刻制出一条长为1m、宽200μm、深50μm的蛇形管道。温度控制在35℃,反应液在反应器中停留15min。收集出口物料,用HPLC检测酶促合成异槲皮苷的得率为89.1%。Prepare 1 g/L rutin mother solution with a pH of 9 with glycine-sodium hydroxide buffer solution, prepare a 0.1 g/mL hesperidinase solution with distilled water, rutin mother solution, enzyme solution and ionic liquid [Bmin][ BF 4 ] were prepared into a biotransformation reaction system at a volume ratio of 72:18:10. The prepared reaction system was pumped into a continuous flow reactor at a flow rate of 4 μL/min through a microsyringe pump for reaction. The structure of the device is the same as that of Example 1. The reactor is made of glass material by etching to carve a serpentine pipe with a length of 1 m, a width of 200 μm, and a depth of 50 μm. The temperature was controlled at 35°C, and the reaction liquid stayed in the reactor for 15 minutes. The export material was collected, and the yield of enzymatically synthesized isoquercitrin was detected by HPLC to be 89.1%.
实施例6Example 6
以甘氨酸-氢氧化钠缓冲液配制pH为9的0.5g/L的芦丁母液,以蒸馏水配制浓度为0.1g/mL的橙皮苷酶溶液,芦丁母液、酶溶液和离子液体[Bmin][BF4]分别按体积比为72:18:10配制成生物转化反应体系。将配制好的反应体系通过微量注射泵,以2μL/min的流速泵入到连续流反应器中进行反应。装置结构与实施例1相同,该反应器由PDMS材质通过热注塑法刻制出一条长为1m、宽100μm、深50μm的蛇形管道。温度控制在35℃,反应液在反应器中停留15min。收集出口物料,用HPLC检测酶促合成异槲皮苷的得率为93.5%。Prepare 0.5g/L rutin mother solution with pH of 9 with glycine-sodium hydroxide buffer solution, prepare hesperidin enzyme solution with concentration of 0.1g/mL with distilled water, rutin mother solution, enzyme solution and ionic liquid [Bmin] [BF 4 ] was prepared into a biotransformation reaction system at a volume ratio of 72:18:10. The prepared reaction system was pumped into a continuous flow reactor at a flow rate of 2 μL/min through a microsyringe pump for reaction. The structure of the device is the same as that of Example 1. The reactor is made of PDMS material and carved a serpentine pipe with a length of 1 m, a width of 100 μm, and a depth of 50 μm by thermal injection molding. The temperature was controlled at 35°C, and the reaction liquid stayed in the reactor for 15 minutes. The export material was collected, and the yield of enzymatically synthesized isoquercitrin was detected by HPLC to be 93.5%.
实施例7Example 7
以甘氨酸-氢氧化钠缓冲液配制pH为9的0.1g/L的芦丁母液,以蒸馏水配制浓度为0.1g/mL的橙皮苷酶溶液,芦丁母液、酶溶液和离子液体[Bmin][BF4]分别按体积比为72:18:10配制成生物转化反应体系。将配制好的反应体系通过微量注射泵,以2μL/min的流速泵入到连续流反应器中进行反应。装置结构与实施例1相同,该反应器由PDMS-玻璃材质通过热注塑法刻制出一条长为2m、宽200μm、深50μm的蛇形管道。温度控制在40℃,反应液在反应器中停留30min。收集出口物料,用HPLC检测酶促合成异槲皮苷的得率为99.9%。Prepare 0.1g/L rutin mother solution with pH of 9 with glycine-sodium hydroxide buffer solution, prepare hesperidin enzyme solution with concentration of 0.1g/mL with distilled water, rutin mother solution, enzyme solution and ionic liquid [Bmin] [BF 4 ] was prepared into a biotransformation reaction system at a volume ratio of 72:18:10. The prepared reaction system was pumped into a continuous flow reactor at a flow rate of 2 μL/min through a microsyringe pump for reaction. The structure of the device is the same as that in Example 1. The reactor is made of PDMS-glass material and carved a serpentine pipe with a length of 2 m, a width of 200 μm, and a depth of 50 μm by hot injection molding. The temperature was controlled at 40°C, and the reaction liquid stayed in the reactor for 30 minutes. The export material was collected, and the yield of enzymatically synthesized isoquercitrin was detected by HPLC to be 99.9%.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310611377.6A CN103627756A (en) | 2013-11-26 | 2013-11-26 | Method for enzymatic synthesis of isoquercitrin by using continuous-flow tubular microreactor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310611377.6A CN103627756A (en) | 2013-11-26 | 2013-11-26 | Method for enzymatic synthesis of isoquercitrin by using continuous-flow tubular microreactor |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103627756A true CN103627756A (en) | 2014-03-12 |
Family
ID=50209204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310611377.6A Pending CN103627756A (en) | 2013-11-26 | 2013-11-26 | Method for enzymatic synthesis of isoquercitrin by using continuous-flow tubular microreactor |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103627756A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105969826A (en) * | 2016-06-17 | 2016-09-28 | 江苏科技大学 | Method for synthesizing isoquercitrin with nano-particle immobilized enzyme special for microreactor |
CN106119319A (en) * | 2016-08-25 | 2016-11-16 | 江苏科技大学 | Recombinant alpha L rhamnoside enzyme extract is catalyzed the method for directionally hydrolyzing flavonoid glycoside in micro passage reaction |
CN107056670A (en) * | 2017-06-13 | 2017-08-18 | 西安万德能源化学股份有限公司 | A kind of preparation method of two tertiary base peroxide |
CN107988283A (en) * | 2018-01-30 | 2018-05-04 | 南京工业大学 | Method for preparing trehalose by adopting microchannel reactor |
CN108467419A (en) * | 2018-03-23 | 2018-08-31 | 四川天添生物科技应用有限公司 | A method of synthesizing isoquercitrin with rutin |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102876746A (en) * | 2012-10-11 | 2013-01-16 | 江苏科技大学 | Method of ionic liquid cosolvent effect reinforced enzymatic synthesis of isoquercitrin |
-
2013
- 2013-11-26 CN CN201310611377.6A patent/CN103627756A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102876746A (en) * | 2012-10-11 | 2013-01-16 | 江苏科技大学 | Method of ionic liquid cosolvent effect reinforced enzymatic synthesis of isoquercitrin |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105969826A (en) * | 2016-06-17 | 2016-09-28 | 江苏科技大学 | Method for synthesizing isoquercitrin with nano-particle immobilized enzyme special for microreactor |
CN105969826B (en) * | 2016-06-17 | 2019-09-27 | 江苏科技大学 | A method for synthesizing isoquercitrin with special nanoparticle immobilized enzyme for microreactor |
CN106119319A (en) * | 2016-08-25 | 2016-11-16 | 江苏科技大学 | Recombinant alpha L rhamnoside enzyme extract is catalyzed the method for directionally hydrolyzing flavonoid glycoside in micro passage reaction |
CN106119319B (en) * | 2016-08-25 | 2019-09-27 | 江苏科技大学 | The method of using the crude extract of recombinant α-L-rhamnosidase in a microchannel reactor to catalyze the directional hydrolysis of flavonoid glycosides |
CN107056670A (en) * | 2017-06-13 | 2017-08-18 | 西安万德能源化学股份有限公司 | A kind of preparation method of two tertiary base peroxide |
CN107988283A (en) * | 2018-01-30 | 2018-05-04 | 南京工业大学 | Method for preparing trehalose by adopting microchannel reactor |
CN108467419A (en) * | 2018-03-23 | 2018-08-31 | 四川天添生物科技应用有限公司 | A method of synthesizing isoquercitrin with rutin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103184251B (en) | Method for on-line synthesizing glucose-6-acetate catalyzed by lipase | |
CN103184253B (en) | Method of using lipase to catalyze and synthesize mannose-6-laurate on line | |
CN103627756A (en) | Method for enzymatic synthesis of isoquercitrin by using continuous-flow tubular microreactor | |
CN103667402B (en) | A kind of lipase-catalyzed online synthesis 6 " method of-O-lauroyl-naringin ester | |
CN103667396B (en) | A kind of lipase-catalyzed online synthesis 6 " method of-O-lauroyl-naringin dihydrochalcone ester | |
CN103184255B (en) | Method of using lipase to catalyze and synthesize galactose-6-acetate on line | |
CN103184249A (en) | Method for on-line synthesizing glucose-6-palmitate by lipase catalysis | |
CN107475330A (en) | A kind of method of lipase-catalyzed online synthesis N (5 glucose ester valeryl) metoprolol | |
CN107384991B (en) | Method for synthesizing 5' -O-ethylene adipamide uridine on line by lipase catalysis | |
CN107488683A (en) | A kind of lipase-catalyzed online synthesis N(5 vinyl acetate valeryls)The method of mexiletine | |
CN109735582B (en) | A kind of method of lipase-catalyzed online synthesis of cyclohexanol β-amino alcohol derivatives | |
CN104086415A (en) | Method for preparing acetyl tributyl citrate by using micro-reaction device | |
CN107488690A (en) | A kind of method of lipase-catalyzed online synthesis N (5 glucose ester valeryl) mexiletine | |
CN103667393B (en) | A kind of lipase-catalyzed online synthesis 6 " method of-O-palmityl-neohesperidin dihydrochalcone ester | |
CN103667400B (en) | A kind of lipase-catalyzed online synthesis 6 " method of-O-palmityl-naringin ester | |
CN109988787B (en) | A kind of lipase catalyzed method for online synthesis of 2-phenylaminocyclohexanol | |
CN103667403B (en) | Enzymatic synthesis of isoquercitrin in a two-phase system by segmented flow microreaction process | |
CN103667394B (en) | A kind of lipase-catalyzed online synthesis 6 " method of-O-lauroyl-neohesperidin dihydrochalcone ester | |
CN103509368B (en) | Method for preparing gardenia blue pigment by supercritical CO2 catalyzed hydrolysis of geniposide | |
CN103468754B (en) | Method for enzymatic synthesis of propyl caffeate by utilizing microreactor | |
CN103667399B (en) | A kind of lipase-catalyzed online synthesis 6 " method of-O-palmityl-Neohesperidin ester | |
CN107418989A (en) | A kind of method of lipase-catalyzed online synthesis N (5 sucrose ester valeryl) metoprolol | |
CN107988283A (en) | Method for preparing trehalose by adopting microchannel reactor | |
CN103184250B (en) | Method for on-line synthesizing mannose-6-acetate by lipase catalysis | |
CN107988278B (en) | Method for synthesizing S-benzyl lauric acid thioester on line by lipase catalysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140312 |